US 5,721,121 A · Mammalian cell culture process for producing a tumor necrosis factor receptor immunoglobulin chimeric protein

Abstract

The present invention relates to novel process for the preparation of glycoproteins by mammalian cell culture wherein the sialic acid content of the glycoprotein produced is controlled over a broad range of values by manipulating the cell culture environment. The invention provides for processes in which the sialic acid content of the glycoprotein is modified by changes in cell culture parameters which affect cell specific productivity. Preferred embodiments of the invention include cell culture processes in the osmolality of the cell culture is controlled as well as the concentration of a transcription enhancer during the production phase of the cell culture. The invention further provides for novel preparations of soluble type 1 tumor necrosis factor immunoglobulin G1 and their uses in the treatment of inflammatory or immune related disorders.

Claims8

Dependent claims

A process for producing a human soluble type 1 tumor necrosis factor receptor-immunoglobin G.sub.1 TNFR1-IgG.sub.1 chimetic protein comprising:

(a) culturing a CHO host cell which expresses a human TNFR1-IgG.sub.1 chimera in a growth phase at a temperature near 37.degree. C. under such conditions and for a period of time such that maximum cell growth is achieved;
(b) culturing the host cell in a production phase:
(1) in the presence of sodium butyrate at a concentration of about 6 mM to about 12 mM;
(2) while maintaining the osmolality at about 450-600 mOsm;
and
(3) while maintaining the temperature about between 30.degree. C. and 35.degree. C.

3 more elements

Dependencies are inferred from the claim text.

Mammalian cell culture process for producing a tumor necrosis factor receptor immunoglobulin chimeric protein

Life of this patent

Mammalian cell culture process for producing a tumor necrosis factor receptor immunoglobulin chimeric protein

Life of this patent

Abstract

Claims8